Drug: Bevacizumab Injury: Abdominal pain Quarter: 2016Q3
Total Records: 30 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
73649854 | Bevacizumab | Abdominal pain | ROCHE | 65.00 YR | M | 93 KG | 20160916 | US |
79980283 | Bevacizumab | Abdominal pain | ROCHE | 53.00 YR | F | 91 KG | 20160930 | US |
81331126 | Bevacizumab | Abdominal pain | ROCHE | 0.00 | F | 0 | 20160912 | US |
82992732 | Bevacizumab | Abdominal pain | ROCHE | 69.00 YR | F | 52 KG | 20160929 | US |
83404846 | Bevacizumab | Abdominal pain | ROCHE | 63.00 YR | F | 116 KG | 20160927 | US |
94076507 | Bevacizumab | Abdominal pain | ROCHE | 57.80 YR | M | 51 KG | 20160804 | GB |
100108357 | Bevacizumab | Abdominal pain | ROCHE | 0.00 | 0 | 20160922 | US | |
101489614 | Bevacizumab | Abdominal pain | ROCHE | 70.00 YR | F | 56 KG | 20160919 | US |
104404043 | Bevacizumab | Abdominal pain | ROCHE | 67.60 YR | M | 95 KG | 20160711 | DE |
105726027 | Bevacizumab | Abdominal pain | ROCHE | 62.60 YR | F | 71 KG | 20160830 | DE |
107434093 | Bevacizumab | Abdominal pain | ROCHE | 39.00 YR | M | 102 KG | 20160905 | US |
125232283 | BEVACIZUMAB | Abdominal pain | AMGEN | 58.00 YR | F | 0 | 20160802 | GB |
125391461 | Bevacizumab | Abdominal pain | CIPLA | 0.00 | 0 | 20160708 | BE | |
125477611 | Bevacizumab | Abdominal pain | ROCHE | 58.00 YR | F | 49 KG | 20160712 | US |
125484302 | Bevacizumab | Abdominal pain | ROCHE | 83.00 YR | F | 70 KG | 20160916 | US |
126014301 | Bevacizumab | Abdominal pain | ROCHE | 56.95 YR | F | 60 KG | 20160728 | US |
126177612 | Bevacizumab | Abdominal pain | ROCHE | 75.00 YR | F | 80 KG | 20160805 | ES |
127227521 | Bevacizumab | Abdominal pain | ROCHE | 15.00 YR | M | 48 KG | 20160907 | US |
127413111 | Bevacizumab | Abdominal pain | ROCHE | 65.23 YR | M | 52 KG | 20160914 | US |
127446291 | Bevacizumab | Abdominal pain | ROCHE | 21.00 YR | M | 55 KG | 20160915 | US |
Total Records: 30 Number of Pages: 2